滙景控股(09968.HK)斥資6.582億元收購江蘇徐州土地使用權
格隆匯 12 月 21日丨滙景控股(09968.HK)發佈公告,2020年12月18日,公司間接全資附屬公司滙景嘉實於掛牌出售中成功中標,以現金代價人民幣6.582億元收購該土地的土地使用權,以開發住宅項目。預期滙景嘉實與徐州局方將於2020年12月底前訂立該協議。
該土地位於江蘇省徐州市賈汪區利大路西側、學院路北側、淮海路東側、華山路南側。總佔地面積9.64萬平方米,建築面積25.16萬平方米,土地使用權年期70年,作住宅用途。
公告稱,該土地位於徐州市,受惠於高鐵帶來的蓬勃發展。公司認為,收購事項為集團繼續其於中國發展策略及增加集團土地儲備的投資良機,並將於未來數年為集團帶來良好收益來源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.